Recommendations for the use of two meningococcal serogroup B vaccines for people at high risk of invasive disease were made by the Centers for Disease Control and Prevention’s (CDC’s) Advisory Committee on Immunization Practices (ACIP) Feb. 26.

The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices recently recommended two meningitis vaccines for high-risk patients. It also endorsed a 9-valent HPV vaccine and rescinded its preference for live attenuated influenza vaccine for the 2015-’16 influenza season.

Inclement weather forced an abbreviated session of the group and delayed consideration of using the vaccines routinely for adolescents and college students until its June meeting.

In other action, the committee endorsed a 9-valent human papillomavirus (HPV )vaccine and agreed most people, including children, don’t need a yellow fever booster following primary immunization. The ACIP also rescinded its preference for live attenuated influenza vaccine (LAIV) and stated for the upcoming 2015-’16 influenza...

You do not currently have access to this content.